Common drugs, uncommon risks? Higher rate of serious problems after short-term steroid use

April 13, 2017

Millions of times a year, Americans get prescriptions for a week's worth of steroid pills, hoping to ease a backache or quell a nagging cough or allergy symptoms. But a new study suggests that they and their doctors might want to pay a bit more attention to the potential side effects of this medication.

People taking the pills were more likely to break a bone, have a potentially dangerous blood clot or suffer a life-threatening bout of sepsis in the months after their treatment, compared with similar adults who didn't use corticosteroids, researchers from the University of Michigan report in a new paper in the British Medical Journal (BMJ).

Though only a small percentage of both groups went to the hospital for these serious health threats, the higher rates seen among people who took for even a few days are cause for caution and even concern, the researchers say.

The study used data from 1.5 million non-elderly American adults with private insurance. One in 5 of them filled a short-term prescription for oral corticosteroids such as prednisone sometime in the three-year study period. While the rates of the serious events were highest in the first 30 days after a prescription, they stayed elevated even three months later.

The researchers call for better education of prescribers and the public about the potential risks, and the most appropriate uses and doses, for short-term courses of steroids. The U.S. Food and Drug Administration require drug makers to list the possible side effects of prednisone and other corticosteroids, but the rate of these events among short-term users has not been well characterized.

"Although physicians focus on the long-term consequences of steroids, they don't tend to think about potential risks from short-term use," says Akbar Waljee, M.D., M.Sc., the study's lead author. "We see a clear signal of higher rates of these three serious events within 30 days of filling a prescription. We need to understand that steroids do have a real risk and that we may use them more than we really need to. This is so important because of how often these drugs are used."

Waljee is an assistant professor of gastroenterology at the U-M Medical School and research scientist at the VA Ann Arbor Healthcare System, as well as a member of the Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP), the U-M Institute for Healthcare Policy and Innovation and the VA Center for Clinical Management Research.

As a specialist in inflammatory bowel diseases, he prescribes steroids often to patients seeking relief from chronic digestive tract issues. But the new study focused on short-term use and risks.

Who's using short-term steroids?

Using anonymous insurance claims data that IHPI purchased for use by U-M health care researchers, they found that half of the people who received had gotten them for just six diagnoses, related to back pain, allergies or respiratory tract infections including bronchitis.

Nearly half received a six-day prepackaged methylprednisolone "dosepak," which tapers the dose of steroids from highest to lowest. Dr. Waljee notes that sold as individual pills, oral steroids can cost less than a dollar for a seven-day course, but the prepackaged form can cost several times that. He also notes that the prepackaged form starts with a relatively high dose that may not always be necessary.

Users of short-term steroids were more likely to be in the older age range under age 65, white, female and to have multiple health conditions. More than half lived in the southern U.S.

The researchers excluded from the study anyone who took steroids in the year before the study period began, anyone who took inhaled or injected steroids during the study years, and anyone who took oral steroids for more than 30 days, as well as people who had cancer or transplants.

Differences in danger

Dr. Waljee and his colleagues found higher rates of sepsis, venous thromboembolism (VTE) and fractures among short-term steroid users using multiple different statistical approaches to ensure their findings were as robust as possible.

First, they compared short-term steroid users with non-steroid users, looking for the three serious issues in the 5 to 90 days after either the clinic visit closest to when the steroid prescription was filled, or a routine clinic visit for non-steroid users. This gives what's called an absolute risk.

They saw that 0.05 percent of those who got steroids were admitted to a hospital with a primary diagnosis of sepsis, compared with 0.02 percent of non-steroid users. For clots, it was 0.14 percent compared with 0.09 percent, and for fracture, it was 0.51 percent compared with 0.39 percent. However, this analysis was unable to account for all the individual differences between steroid users and non-users.

For that comparison, they then looked at rates of the three complications among short-term steroid users before and after they received steroids. Sepsis rates were five times higher in the 30 days after a steroid prescription, VTE clot rates were more than three times as high, and fracture rates were nearly twice as high as those that did not take steroids.

Finally, the researchers compared the steroid users with a sample of non-steroid users who had the same respiratory conditions. The difference in rates of all three health problems were still higher, as expressed by a quantity called the incidence rate ratio. Steroid users had more than five times the rate of sepsis, nearly three times the rate of VTE clots and two times the rate of fracture.

The consistent findings across the three approaches are important given the frequent use of these drugs and potential implications for patients. Waljee notes that the reason for this broad effect of steroids on complications may have its roots in how the drugs work: they mimic hormones produced by the body, to reduce inflammation but this can also induce changes that put patients at additional risk of serious events.

Studies in populations like the one in the BMJ paper can help guide researchers looking for dangerous side effects once drugs are on the market. Waljee notes the FDA is also conducting these initiatives through the "Sentinel Initiative". These studies can also provide insight into the possible mechanisms that might drive these side effects.

"When we have a medication that's being given to a large population, we can pick up signals that might inform us of some potentially harmful side effects that we might otherwise miss in smaller studies," he says. "Analyzing large data sets like this is a goal of groups like MiCHAMP and can help us see these trends sooner, highlighting the importance of this type of research on Big Data."

In the meantime, based on the new results, he advises patients and prescribers to use the smallest amount of corticosteroids possible based on the condition being treated. "If there are alternatives to steroids, we should be use those when possible," he says. "Steroids may work faster, but they aren't as risk-free as you might think."

Explore further: Scapegoating steroids is harmful

More information: Akbar K Waljee et al, Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study, BMJ (2017). DOI: 10.1136/bmj.j1415

Related Stories

Scapegoating steroids is harmful

January 13, 2014
Scott Griffiths is a PhD candidate at the University of Sydney's School of Psychology who is currently conducting research on muscle dysmorphia, appearance and performance-enhancing drug use.

Clinical trial reveals a safer long term treatment for blistering skin disease

March 7, 2017
A clinical trial into the treatment of the severe blistering skin condition 'bullous pemphigoid' has found that starting treatment with an oral antibiotic is an effective and safer alternative to the current standard treatment ...

Oral steroids linked to severe vitamin D deficiency in nationwide study

September 29, 2011
People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine ...

Low dose steroids linked to diabetes

February 11, 2014
(Medical Xpress)—Anti-inflammatory steroids are known to increase the risk of diabetes in high doses, but now researchers from Flinders University have discovered a link between low dose steroids and diabetes.

Steroid use much higher among gay and bi teen boys

February 3, 2014
Gay and bisexual teen boys in the U.S. use illicit steroids at a rate almost six times higher than do straight kids, a "dramatic disparity" that points up a need to reach out to this group, researchers say.

The harmful use of topical steroids in India is out of control, says expert

November 25, 2015
The widespread misuse of skin creams and lotions that contain steroids in India is harmful and out of control, argues an expert in The BMJ this week.

Recommended for you

To reduce postoperative pain, consider sleep—and caffeine

August 18, 2017
Sleep is essential for good mental and physical health, and chronic insufficient sleep increases the risk for several chronic health problems.

Despite benefits, half of parents against later school start times

August 18, 2017
Leading pediatrics and sleep associations agree: Teens shouldn't start school so early.

Doctors exploring how to prescribe income security

August 18, 2017
Physicians at St. Michael's Hospital are studying how full-time income support workers hired by health-care clinics can help vulnerable patients or those living in poverty improve their finances and their health.

Schoolchildren who use e-cigarettes are more likely to try tobacco

August 17, 2017
Vaping - or the use of e-cigarettes - is widely accepted as a safer option for people who are already smoking.

Federal snack program does not yield expected impacts, researchers find

August 17, 2017
A well-intentioned government regulation designed to offer healthier options in school vending machines has failed to instill better snacking habits in a sample of schools in Appalachian Virginia, according to a study by ...

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.